Estimands for recurrent event endpoints in the presence of a terminal event
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estimands for recurrent event endpoints in the presence of a terminal event
Authors
Keywords
-
Journal
Statistics in Biopharmaceutical Research
Volume -, Issue -, Pages 1-29
Publisher
Informa UK Limited
Online
2021-03-01
DOI
10.1080/19466315.2021.1895883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A causal framework for classical statistical estimands in failure‐time settings with competing events
- (2020) Jessica G. Young et al. STATISTICS IN MEDICINE
- A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks
- (2020) Yanxun Xu et al. BIOSTATISTICS
- The win ratio: On interpretation and handling of ties
- (2019) Gaohong Dong et al. Statistics in Biopharmaceutical Research
- Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice
- (2019) C. H. Mallinckrodt et al. Therapeutic Innovation & Regulatory Science
- A constructive critique of the draft ICH E9 Addendum
- (2019) Daniel O Scharfstein Clinical Trials
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence
- (2019) Baldur P. Magnusson et al. STATISTICS IN MEDICINE
- Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
- (2019) Frank Pétavy et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Causal Inference and Estimands in Clinical Trials
- (2019) Ilya Lipkovich et al. Statistics in Biopharmaceutical Research
- Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study
- (2018) Brian Claggett et al. STATISTICS IN MEDICINE
- Limitations of hazard ratios in clinical trials
- (2018) Mats J Stensrud et al. EUROPEAN HEART JOURNAL
- Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
- (2017) Naoki Sato et al. JOURNAL OF CARDIAC FAILURE
- Estimands and Their Role in Clinical Trials
- (2017) Mouna Akacha et al. Statistics in Biopharmaceutical Research
- Inference in randomized trials with death and missingness
- (2016) Chenguang Wang et al. BIOMETRICS
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
- (2016) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components
- (2016) Gaohong Dong et al. PHARMACEUTICAL STATISTICS
- Estimands in clinical trials - broadening the perspective
- (2016) Mouna Akacha et al. STATISTICS IN MEDICINE
- Semiparametric regression for the weighted composite endpoint of recurrent and terminal events
- (2015) Lu Mao et al. BIOSTATISTICS
- Does Cox analysis of a randomized survival study yield a causal treatment effect?
- (2015) Odd O. Aalen et al. LIFETIME DATA ANALYSIS
- A taxonomy of estimands for regulatory clinical trials with discontinuations
- (2015) Thomas Permutt STATISTICS IN MEDICINE
- Choosing Appropriate Estimands in Clinical Trials
- (2015) Ann-Kristin Leuchs et al. Therapeutic Innovation & Regulatory Science
- Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints
- (2014) B. Claggett et al. BIOSTATISTICS
- Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
- (2014) Jennifer K. Rogers et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
- (2014) Jennifer K. Rogers et al. JACC-Heart Failure
- Moving beyond our comfort zone
- (2013) Brian Claggett et al. EUROPEAN HEART JOURNAL
- Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia
- (2012) Sumeet Subherwal et al. AMERICAN HEART JOURNAL
- Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?
- (2012) S. D. Anker et al. EUROPEAN HEART JOURNAL
- A Refreshing Account of Principal Stratification
- (2012) Fabrizia Mealli et al.
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Composite outcomes: weighting component events according to severity assisted interpretation but reduced statistical power
- (2010) Uchechukwu K.A. Sampson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- A Global Ranking Approach to End Points in Trials of Mechanical Circulatory Support Devices
- (2008) G. Michael Felker et al. JOURNAL OF CARDIAC FAILURE
- Randomization Does Not Justify Logistic Regression
- (2008) David A. Freedman STATISTICAL SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started